23:02 , Nov 17, 2016 |  BC Innovations  |  Product R&D

Hemorrhaging targets

An analysis of the almost 5,000 abstracts set to be presented at the 2016 American Society of Hematology (ASH) meeting next month indicates this year’s hot topics in preclinical research include a spattering of new...
07:00 , Oct 6, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: PBX homeobox 1 (PBX1); Janus kinase-1 (JAK-1); JAK-2

Cancer INDICATION: Ovarian cancer Patient sample, cell culture and mouse studies suggest inhibiting PBX1 or JAK-2 could help treat chemotherapy-resistant ovarian cancer. In tissue samples from patients with high-grade serous ovarian cancer, levels of PBX1 were higher...